Keep away from concomitant use of tucatinib with CYP3A substrates, where nominal concentration changes could cause really serious or everyday living-threatening toxicities. If unavoidable, lessen CYP3A substrate dose according to solution labeling. amobarbital will decrease the level or impact of diazepam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an https://alank058zei6.blog-gold.com/profile